Table 2.
Results from the negative binomial portion of the ZINB models [exp(B), 95% confidence intervals, p-value] estimating the effect of sleep variables (PSQI score, ISI score, TST) and confounding factors (age, gender, BMI) in April 2020 on the number of long-term symptoms one month (M1, M2, M3) and three months after COVID-19 (M4, M5, M6).
| exp(B) |
95% CI |
p |
exp(B) |
95% CI |
p |
exp(B) |
95% CI |
p |
|
|---|---|---|---|---|---|---|---|---|---|
| M1: sleep quality | M2: insomnia severity | M3: sleep duration | |||||||
| Intercept | 2.325 | 1.461–3.699 | < 0.001 | 2.315 | 1.465–3.658 | < 0.001 | 9.182 | 4.494–18.761 | < 0.001 |
| Gender* | 0.912 | 0.724–1.149 | 0.433 | 0.878 | 0.701–1.101 | 0.260 | 0.819 | 0.649–1.034 | 0.093 |
| Age | 0.990 | 0.983–0.998 | 0.009 | 0.992 | 0.984–0.999 | 0.030 | 0.987 | 0.979–0.995 | 0.001 |
| BMI | 1.023 | 1.006–1.041 | 0.008 | 1.024 | 1.006–1.041 | 0.008 | 1.026 | 1.008–1.045 | 0.004 |
| PSQI score | 1.070 | 1.046–1.094 | < 0.001 | ||||||
| ISI score | 1.049 | 1.033–1.064 | < 0.001 | ||||||
| TST (hour) | 0.889 | 0.840–0.941 | < 0.001 | ||||||
| M4: sleep quality | M5: insomnia severity | M6: sleep duration | |||||||
| Intercept | 1.312 | 0.551–3.124 | 0.540 | 1.706 | 0.776–3.752 | 0.184 | 8.668 | 2.478–30.317 | 0.001 |
| Gender* | 0.925 | 0.592–1.446 | 0.733 | 0.999 | 0.644–1.550 | 0.997 | 0.816 | 0.522–1.278 | 0.375 |
| Age | 1.002 | 0.987–1.018 | 0.772 | 1.002 | 0.988–1.017 | 0.746 | 0.996 | 0.980–1.012 | 0.628 |
| BMI | 1.021 | 0.990–1.054 | 0.184 | 1.017 | 0.986–1.048 | 0.284 | 1.027 | 0.995–1.059 | 0.097 |
| PSQI score | 1.091 | 1.047–1.136 | < 0.001 | ||||||
| ISI score | 1.054 | 1.027–1.082 | < 0.001 | ||||||
| TST (hour) | 0.853 | 0.769–0.946 | 0.003 | ||||||
Notes: *Female was used as reference for “Gender” factor; significant values are in bold.
Abbreviations: BMI, Body mass index; CI, Confidence interval; ISI, Insomnia Severity Index; M, Model; PSQI, Pittsburgh Sleep Quality Index; TST, Total sleep time.